| Mechanism-based design of agents that selectively target drug-resistant glioma K Lin, SE Gueble, RK Sundaram, ED Huseman, RS Bindra, SB Herzon Science 377 (6605), 502-511, 2022 | 52 | 2022 |
| Luteolin Decreases Epidermal Growth Factor Receptor‐Mediated Cell Proliferation and Induces Apoptosis in Glioblastoma Cell Lines DM Anson, RM Wilcox, ED Huseman, TA Stump, RL Paris, BO Darkwah, ... Basic & Clinical Pharmacology & Toxicology 123 (6), 678-686, 2018 | 43 | 2018 |
| The antiproliferative and apoptotic effects of apigenin on glioblastoma cells TA Stump, BN Santee, LP Williams, RA Kunze, CE Heinze, ED Huseman, ... Journal of pharmacy and pharmacology 69 (7), 907-916, 2017 | 38 | 2017 |
| The DARK side of total synthesis: strategies and tactics in psychoactive drug production SA Chambers, JM DeSousa, ED Huseman, SD Townsend ACS chemical neuroscience 9 (10), 2307-2330, 2018 | 30 | 2018 |
| Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists JO Witt, AL McCollum, MA Hurtado, ED Huseman, DE Jeffries, KJ Temple, ... Bioorganic & medicinal chemistry letters 26 (10), 2481-2488, 2016 | 22 | 2016 |
| Synthesis and cytotoxic evaluation of arimetamycin A and its daunorubicin and doxorubicin hybrids ED Huseman, JAW Byl, SM Chapp, ND Schley, N Osheroff, SD Townsend ACS Central Science 7 (8), 1327-1337, 2021 | 14 | 2021 |
| De novo synthesis of an L-lemonose thioglycoside donor from D-Threonine ED Huseman, SD Townsend Tetrahedron letters 73, 153097, 2021 | 3 | 2021 |
| Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers E Huseman, A Lo, O Fedorova, J Elia, S Gueble, K Lin, R Sundaram, ... | | 2023 |
